| Bexarotene |
ENSG00000088970.11 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000088970.11 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000117242.7 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000125804.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000146666.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000149656.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000152931.7 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000157306.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000160336.10 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000166770.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000166770.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000170161.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000170590.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000171889.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000172250.10 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000174171.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000175611.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000175699.8 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000177757.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000177853.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000178412.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000178977.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000179141.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000179523.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000179935.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000180846.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000180846.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000182057.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000182057.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000182648.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000183242.7 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000183535.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000185168.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000185186.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000185186.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000185837.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000186594.8 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000187156.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000187621.10 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000187621.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000187904.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000188365.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000189238.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000189419.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000196668.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000196951.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000197291.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000197332.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000197670.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000197813.4 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000197934.4 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000197989.9 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000203280.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000203325.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000203327.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000203496.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000203650.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000203875.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000203999.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000204054.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000204241.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000204241.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000204272.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000204362.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000204380.2 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000204625.6 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000204706.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000204791.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000204860.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000204860.4 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000205015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000205424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000205500.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000205662.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000205663.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000205663.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000205890.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000205890.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000205959.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000206113.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000206140.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000206142.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000206195.6 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000212163.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000212930.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000213863.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000213971.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000213994.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000214353.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000214432.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000214725.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000214770.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000214870.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000214894.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000214922.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000214922.5 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000215159.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000215244.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000215386.6 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000215447.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000215769.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000215769.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000215841.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000222043.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000223380.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000223403.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000223478.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000223571.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000223573.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000223579.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000223617.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000223643.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000223653.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000223697.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000223734.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000223751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000223759.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000223759.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000223759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000223784.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000223813.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000223834.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000223839.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000223855.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000223884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000223891.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000223911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000223949.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000223960.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000224034.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000224046.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000224049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224078.8 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000224095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224165.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224251.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000224260.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000224342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224376.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000224409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224429.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224478.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224481.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000224481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224574.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000224592.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000224596.3 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000224596.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000224597.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000224621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224635.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000224687.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000224687.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000224691.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000224707.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000224713.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224715.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000224717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224745.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000224758.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000224799.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000224805.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224812.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000224814.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224817.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224883.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224885.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224885.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224934.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000224972.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000224973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000225039.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000225075.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000225076.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000225083.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000225092.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000225111.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000225113.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000225127.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000225194.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000225194.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000225205.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000225213.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000225234.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000225269.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000225284.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000225315.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000225411.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000225493.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000225527.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000225528.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000225532.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000225649.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000225652.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000225733.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000225742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000225767.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000225791.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000225792.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000225806.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000225873.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000225880.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000225889.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000225891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000225913.2 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000225946.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000225953.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000225988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000226017.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000226029.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000226029.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000226067.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000226067.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000226087.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000226200.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000226206.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000226328.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000226330.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000226332.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000226349.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000226380.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000226381.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000226383.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000226386.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000226416.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000226419.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000226472.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000226571.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000226604.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000226629.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000226637.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000226686.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000226699.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000226716.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000226747.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000226751.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000226756.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000226758.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000226772.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000226786.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000226822.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000226828.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000226851.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000226862.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000226862.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000226869.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000226891.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000226917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000226944.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000226950.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000226969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000227014.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000227036.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000227060.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000227068.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000227076.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000227082.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000227107.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000227110.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000227192.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000227195.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000227197.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000227210.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000227215.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000227248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000227285.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000227285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000227308.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000227352.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000227359.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000227388.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000227392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000227484.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000227486.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000227487.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000227496.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000227502.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000227502.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000227527.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000227540.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000227589.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000227617.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000227617.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000227634.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000227695.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000227698.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000227704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000227740.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000227740.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000227744.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000227811.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000227848.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000227857.2 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000227885.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000227895.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000227906.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000227959.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000228028.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000228086.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000228108.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000228115.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000228124.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000228126.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000228135.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000228141.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000228153.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000228172.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000228251.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000228288.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000228313.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000228340.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000228340.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000228352.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000228353.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000228389.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000228389.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000228404.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000228430.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000228487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000228544.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000228554.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000228566.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000228624.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000228624.3 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000228629.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000228639.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000228643.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000228679.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000228701.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000228737.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000228742.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000228786.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000228793.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000228812.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000228817.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000228826.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000228852.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000228878.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000228939.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000229021.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000229065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000229118.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000229118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000229124.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000229127.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000229152.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000229152.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000229153.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000229155.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000229214.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000229227.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000229261.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000229262.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000229272.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000229311.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000229327.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000229330.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000229331.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000229368.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000229404.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000229444.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000229512.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000229525.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000229582.2 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000229587.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000229587.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000229628.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000229645.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000229672.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000229719.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000229727.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000229766.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000229770.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000229776.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000229807.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000229832.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000229839.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000229841.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000229848.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000229852.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000229867.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000229869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000229891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000229893.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000229915.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000229953.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000229999.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000230002.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000230005.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000230023.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000230074.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000230098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000230102.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000230107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000230124.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000230155.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000230285.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000230314.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000230323.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000230337.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000230337.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000230366.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000230408.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000230439.2 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000230499.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000230530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000230537.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000230555.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000230563.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000230612.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000230663.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000230679.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000230724.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000230730.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000230732.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000230735.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000230753.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000230894.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000230914.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000230918.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000230922.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000230925.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000231064.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000231079.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231102.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000231121.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000231121.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231193.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000231196.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231201.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000231227.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231295.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231298.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000231305.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000231305.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231324.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000231327.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000231334.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231336.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000231393.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000231437.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231521.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000231527.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000231551.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000231551.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231628.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000231646.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000231652.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000231690.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231705.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231728.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000231734.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231742.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231742.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000231769.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231770.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000231772.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231789.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000231795.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000231806.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000231840.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000231856.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000231889.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231889.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000231964.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000231969.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000232002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232044.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232057.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232063.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000232082.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000232093.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000232117.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000232118.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000232162.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232233.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000232300.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232324.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232352.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000232363.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232386.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232412.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000232412.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232415.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000232445.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000232445.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000232455.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232455.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000232470.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000232485.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232504.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000232519.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000232533.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000232539.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000232545.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000232545.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000232593.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232600.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000232611.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232611.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232623.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000232633.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000232640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232648.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000232656.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232692.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232710.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000232712.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000232732.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232754.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000232756.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000232811.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000232814.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232827.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232860.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000232876.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232903.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000232909.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000232913.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000232973.7 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000233006.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000233077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233081.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000233144.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000233154.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233220.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000233237.2 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000233242.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233244.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233246.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000233355.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000233411.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000233430.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233478.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233509.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000233515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000233522.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233547.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000233602.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000233621.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000233621.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000233621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233642.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233644.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233754.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233757.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233775.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000233785.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000233785.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000233799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000233800.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233806.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000233806.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233825.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000233847.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000233847.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000233852.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000233858.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233860.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233885.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000233903.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000233906.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233930.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000233942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000234050.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000234062.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000234134.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000234161.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000234181.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000234183.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000234206.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000234222.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000234432.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000234432.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000234449.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000234459.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000234459.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000234504.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000234509.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000234571.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000234601.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000234661.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000234665.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000234676.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000234694.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000234705.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000234707.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000234715.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000234741.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000234753.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000234773.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000234789.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000234793.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000234807.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000234869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000234883.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000234912.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000234921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000234929.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000234943.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000234978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000234996.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000235005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000235033.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000235052.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000235070.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000235078.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000235106.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000235138.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000235159.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000235159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000235214.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000235236.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000235244.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000235246.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000235257.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000235257.4 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000235298.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000235326.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000235398.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000235398.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000235448.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000235461.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000235522.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000235609.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000235652.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000235660.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000235663.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000235724.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000235726.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000235751.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000235760.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000235772.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000235777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000235781.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000235899.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000235934.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000235939.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000235999.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000235999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000236075.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000236144.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000236166.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000236173.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000236188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000236226.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000236230.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000236255.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000236256.5 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000236308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000236333.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000236384.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000236423.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000236467.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000236526.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000236526.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000236545.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000236545.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000236556.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000236558.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000236558.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000236601.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000236627.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000236668.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000236711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000236751.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000236757.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000236772.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000236799.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000236824.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000236869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000236869.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000236896.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000236901.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000236908.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000236915.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000236943.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000236943.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000236986.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000236991.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000237015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000237027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237036.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000237037.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000237094.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000237133.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000237152.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237253.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000237301.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000237321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237328.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000237337.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237356.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000237419.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000237424.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000237436.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000237453.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237471.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237476.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237502.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000237505.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237505.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000237512.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000237523.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000237523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237525.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000237637.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237646.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000237685.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237742.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237756.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000237853.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237870.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000237886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237919.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237928.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237934.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000237937.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237938.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000237938.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000237940.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237943.2 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000237976.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237978.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000237980.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237989.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237989.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000237998.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000238009.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000238035.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000238057.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000238097.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000238107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000238113.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000238123.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000238142.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000238178.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000238197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000238197.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000238224.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000238273.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000238279.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000239213.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000239353.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000239415.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000239523.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000239705.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000239906.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000239920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000239945.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000239994.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000240063.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000240086.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000240291.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000240405.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000240553.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000240618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000240859.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000240990.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000241014.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000241054.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000241101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000241125.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000241135.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000241219.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000241269.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000241288.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000241472.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000241475.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000241679.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000241770.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000241770.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000241770.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000241956.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000242042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000242049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000242086.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000242125.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000242540.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000242553.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000242578.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000242759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000242791.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000242861.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000243193.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000243368.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000243415.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000243701.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000243810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000243849.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000243960.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000244040.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000244161.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000244198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000244198.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000244219.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000244252.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000244286.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000244300.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000244302.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000244327.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000244332.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000244332.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000244459.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000244479.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000244513.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000244558.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000244649.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000244757.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000244757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000244945.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000245105.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000245149.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000245149.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000245281.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000245311.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000245532.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000245532.4 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000245534.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000245571.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000245571.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000245648.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000245648.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000245685.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000245748.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000245768.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000245849.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000245849.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000245857.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000245869.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000246090.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000246174.3 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000246174.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000246308.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000246323.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000246339.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000246528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000246582.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000246640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000246662.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000246792.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000246820.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000246851.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000246859.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000246877.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000246889.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000247081.3 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000247131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000247228.2 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000247373.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000247416.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000247556.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000247675.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000247708.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000247774.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000247853.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000247950.2 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000248103.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000248152.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000248161.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000248187.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000248187.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000248202.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000248240.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000248266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000248323.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000248367.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000248514.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000248544.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000248596.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000248668.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000248668.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000248671.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000248690.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000248693.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000248758.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000248774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000248802.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000248810.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000248866.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000248936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000248994.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000248996.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000248996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000249084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000249167.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000249207.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000249249.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000249249.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000249252.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000249267.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000249304.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000249307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000249310.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000249359.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000249417.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000249430.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000249456.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000249456.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000249463.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000249464.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000249484.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000249502.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000249509.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000249532.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000249604.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000249635.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000249669.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000249685.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000249685.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000249695.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000249731.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000249740.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000249790.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000249791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000249846.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000249846.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000249867.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000249868.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000249906.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000249996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000250056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000250103.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000250116.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000250155.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000250271.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000250286.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000250295.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000250320.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000250360.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000250365.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000250366.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000250397.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000250407.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000250410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000250421.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000250490.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000250519.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000250659.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000250659.2 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000250786.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000250838.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000250838.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000250874.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000250899.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000250900.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000250900.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000250900.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000250909.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000251003.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251011.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251018.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000251072.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000251072.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251141.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000251168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251169.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251175.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000251179.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251187.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251191.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251194.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000251221.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251259.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000251307.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251314.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251323.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000251330.3 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000251361.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251364.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000251365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000251405.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000251417.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000251432.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251497.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251513.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000251513.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000251513.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251532.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251555.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000251584.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251598.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251602.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000251604.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000251623.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000251661.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000251661.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000251666.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000253111.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000253112.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000253210.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000253210.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000253230.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000253266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000253284.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000253317.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000253374.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000253374.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000253385.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000253392.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000253399.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000253404.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000253430.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000253477.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000253522.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000253522.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000253552.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000253557.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000253576.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000253596.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000253616.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000253641.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000253669.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000253671.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000253671.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000253678.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000253695.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000253704.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000253737.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000253796.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000253832.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000253837.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000253853.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000253854.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000253859.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000253878.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000253878.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000253893.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000253921.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000253929.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000253961.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000253978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000253986.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000254008.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254035.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254060.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254099.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000254099.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000254109.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254153.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254165.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000254207.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254246.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254266.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000254271.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254286.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254302.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254303.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254319.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254325.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254347.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254363.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000254389.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000254427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254451.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000254459.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000254459.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254510.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000254510.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254539.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000254551.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000254554.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000254556.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254557.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254560.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000254566.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254602.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000254604.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000254604.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000254606.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254610.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254632.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254689.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254777.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254802.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254847.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254847.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000254869.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000254879.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254900.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000254929.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000254934.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254936.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000254973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000255008.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000255027.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000255031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000255089.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000255100.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000255118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000255121.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000255135.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000255164.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000255176.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000255236.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000255240.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000255241.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000255276.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000255299.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000255308.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000255310.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000255310.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000255318.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000255322.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000255328.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000255348.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000255395.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000255409.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000255418.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000255434.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000255456.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000255458.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000255474.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000255474.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000255476.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000255509.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000255542.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000255559.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000255565.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000255568.2 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000255571.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000255867.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000255920.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000255933.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000255933.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000255970.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000256031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000256050.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000256116.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000256139.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000256150.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000256155.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000256250.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000256268.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000256278.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000256360.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000256377.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000256381.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000256442.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000256538.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000256576.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000256576.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000256588.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000256588.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000256654.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000256742.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000256790.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000256802.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000256824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000256862.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000256894.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000256955.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000257027.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000257056.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000257083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000257095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000257120.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000257126.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000257139.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000257139.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000257239.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000257252.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000257258.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000257261.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000257264.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000257272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000257277.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000257283.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000257285.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000257346.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000257433.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000257452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000257456.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000257497.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000257527.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000257527.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000257530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000257534.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000257543.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000257551.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000257660.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000257702.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000257718.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000257718.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000257732.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000257754.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000257809.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000257817.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258001.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000258017.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000258044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258050.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258099.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000258122.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000258136.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000258175.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258175.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000258274.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000258279.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000258302.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000258323.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000258323.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000258323.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000258325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000258343.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000258441.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000258457.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258458.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000258497.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258498.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258520.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000258520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258593.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258636.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258646.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000258657.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000258658.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000258673.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258689.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000258689.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258730.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000258736.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258760.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258857.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258858.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258904.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000258938.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000258940.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258957.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000258959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000258959.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000258983.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000259006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259055.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259071.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000259083.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000259084.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259138.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000259158.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000259163.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000259201.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000259209.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000259235.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259238.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259238.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000259238.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000259241.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259274.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000259294.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000259296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259310.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000259319.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000259364.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000259364.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000259396.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259408.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000259418.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000259426.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000259442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000259443.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000259453.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000259453.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259459.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259462.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000259462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259462.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000259475.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000259515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000259523.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259540.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000259543.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259549.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259551.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000259561.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000259563.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000259577.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000259583.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000259583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000259628.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000259628.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000259645.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000259652.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259654.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000259663.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259668.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000259668.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000259682.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259690.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259705.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259723.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000259727.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000259756.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259764.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259771.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000259771.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259771.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259804.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000259806.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000259818.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000259820.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000259834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259883.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000259899.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000259920.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000259969.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000259974.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000259986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260011.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260018.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000260037.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000260037.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000260038.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000260093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000260115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260118.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000260118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260132.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000260141.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000260156.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000260167.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000260176.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000260193.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260196.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000260197.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000260198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260219.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000260248.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000260261.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000260281.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000260293.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000260352.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260352.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000260366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000260369.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000260398.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260423.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000260436.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000260441.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260466.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260493.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000260517.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000260523.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260528.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000260534.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260536.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000260541.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000260563.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000260583.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260593.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260608.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000260608.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000260612.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260614.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260626.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260630.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000260633.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000260643.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000260643.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000260648.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000260651.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000260655.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000260671.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260671.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000260672.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000260693.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000260698.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000260708.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000260742.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000260777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000260787.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260804.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000260805.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000260830.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000260831.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260874.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000260891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000260898.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260923.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000260929.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000260931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260936.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260948.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000260954.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000260973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000260988.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000261013.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261018.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261019.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000261024.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261024.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261045.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261068.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000261068.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261094.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000261096.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000261098.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000261114.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261126.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261131.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000261131.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000261159.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000261159.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000261159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261167.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000261167.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000261186.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261216.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261218.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261267.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000261273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261288.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000261291.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000261291.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000261337.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000261342.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000261373.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000261374.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000261374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261384.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261420.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000261431.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000261431.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000261438.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000261441.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000261447.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261455.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000261462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000261485.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261490.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000261496.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261512.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000261521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261533.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000261534.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000261550.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000261570.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261578.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261582.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000261610.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000261610.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000261618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000261645.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261662.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261685.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000261690.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261692.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261712.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000261729.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000261760.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000261775.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000261780.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000261797.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000261838.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000261839.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000261916.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000261924.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000261996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000262001.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000262094.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000262115.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000262119.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000262136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000262165.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000262179.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000262188.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000262202.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000262202.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000262222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000262294.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000262380.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000262434.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000262468.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000262521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000262652.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000262652.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000262678.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000262693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000262721.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000262745.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000262810.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000262881.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000262973.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000263004.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000263011.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000263013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000263015.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000263033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000263069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000263096.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000263098.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000263105.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000263105.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000263220.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000263257.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000263300.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000263321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000263388.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000263393.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000263412.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000263466.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000263499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000263618.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000263657.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000263680.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000263717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000263718.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000263727.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000263766.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000263847.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000263906.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000263938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000264007.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000264026.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000264043.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000264112.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000264270.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000264301.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000264486.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000264527.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000264589.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000264630.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000264735.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000264859.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000264860.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000264885.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000264914.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000264937.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000264968.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000264968.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000264968.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000265000.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000265094.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000265130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000265142.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000265246.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000265316.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000265334.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000265349.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000265479.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000265496.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000265688.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000265692.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000265728.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000265791.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000265888.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000265908.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000265943.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000265992.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000266040.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000266126.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000266236.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000266290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000266304.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000266446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000266466.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000266498.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000266521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000266538.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000266599.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000266651.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000266654.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000266667.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000266717.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000266718.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000266801.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000266803.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000266835.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000266896.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000266901.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000266911.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000266912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000266916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000266922.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000266935.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000266942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000266983.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000266993.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000267004.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267006.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000267052.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000267058.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000267093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000267095.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000267095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267104.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000267115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267118.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000267136.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267144.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267192.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267194.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000267202.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267212.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000267222.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000267248.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267251.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267254.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267255.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267268.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267280.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000267280.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000267284.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267288.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267288.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000267289.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000267289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267299.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000267302.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000267311.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267316.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267347.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000267348.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000267366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267374.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000267374.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000267381.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267388.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000267405.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000267424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267429.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267432.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000267439.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000267446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267454.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267505.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000267510.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000267530.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267549.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000267549.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267565.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267581.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000267583.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000267606.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267626.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267637.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000267651.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000267655.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000267658.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000267672.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267701.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000267701.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267730.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000267731.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000267734.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000267735.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267747.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000267751.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000267776.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267786.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000267798.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267834.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000267858.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000267886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267898.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000267904.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000267905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267919.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000267919.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000267927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000267940.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000267986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000268015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000268047.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000268049.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000268049.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000268189.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000268199.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000268199.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000268230.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000268231.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000268266.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000268266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000268289.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000268307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000268340.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000268392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000268401.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000268401.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000268458.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000268496.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000268499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000268520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000268543.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000268564.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000268564.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000268573.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000268655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000268670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000268743.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000268756.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000268756.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000268873.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000268894.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000268895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000268912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000268987.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000269044.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000269044.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000269054.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000269054.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000269107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000269194.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000269220.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000269235.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000269293.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000269387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000269397.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000269425.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000269425.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000269473.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000269473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000269487.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000269534.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000269574.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000269609.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000269653.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000269680.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000269696.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000269752.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000269814.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000269825.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000269825.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000269834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000269836.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000269843.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000269893.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000269895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000269896.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000269901.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000269903.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000269903.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000269918.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000269918.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000269924.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000269938.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000269946.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000269949.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000269949.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000269956.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000269959.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000269966.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000269974.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000269985.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000270010.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000270020.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000270022.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000270035.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000270036.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000270036.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000270039.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000270041.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000270050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000270062.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000270066.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000270067.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000270074.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000270076.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000270083.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000270084.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000270091.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000270095.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000270105.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000270109.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000270115.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000270124.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000270127.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000270143.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000270145.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000270159.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000270170.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000270171.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000270178.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000270178.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000270189.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000270190.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000270190.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000270210.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000270332.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000270332.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000270344.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000270346.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000270346.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000270346.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000270361.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000270426.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000270462.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000270562.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000270604.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000270605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000270607.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000270640.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000270704.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000270760.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000270988.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000270988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000271032.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000271032.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000271119.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000271199.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000271199.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000271265.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000271308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000271314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000271320.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000271324.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000271344.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000271347.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000271366.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000271417.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000271553.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000271553.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000271576.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000271590.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000271590.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000271659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000271709.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000271751.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000271755.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000271755.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000271757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000271782.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000271789.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000271803.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000271815.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000271830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000271835.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000271857.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000271871.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000271927.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000271943.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000271947.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000271948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000271948.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000271952.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000271981.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000271983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000271991.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000272002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272004.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000272005.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272023.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000272029.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000272030.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000272033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272040.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000272057.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000272057.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000272065.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000272065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272065.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000272068.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272077.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000272088.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000272088.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272093.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000272097.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000272112.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000272121.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000272123.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000272128.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000272128.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000272130.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272137.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272142.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000272143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000272143.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272143.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000272158.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000272191.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000272192.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000272192.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000272233.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272239.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272240.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000272248.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000272264.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000272282.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272343.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000272346.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000272365.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000272370.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000272372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272377.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000272379.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000272379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272382.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000272389.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000272389.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000272402.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000272403.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000272416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272425.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272452.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000272452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272457.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000272473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272498.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000272498.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000272505.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272508.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000272516.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272516.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000272524.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000272544.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000272554.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000272554.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272556.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000272622.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000272627.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000272650.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000272659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272660.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000272672.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272691.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272699.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Bexarotene |
ENSG00000272699.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000272707.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000272709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272716.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000272721.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000272721.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000272733.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000272744.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000272755.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272764.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000272769.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000272769.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000272800.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000272824.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000272828.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272853.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000272871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272872.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000272892.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000272904.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000272911.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000272914.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000272917.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000272933.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000272933.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000273001.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000273001.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000273004.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000273004.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000273004.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000273011.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000273018.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000273065.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000273084.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000273091.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000273091.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000273108.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000273108.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000273116.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000273125.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000273129.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000273129.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000273143.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Bexarotene |
ENSG00000273174.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000273174.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000273179.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000273186.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Bexarotene |
ENSG00000273186.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000273203.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000273209.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000273230.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000273237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Bexarotene |
ENSG00000273245.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000273257.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000273265.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Bexarotene |
ENSG00000273267.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000273281.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000273293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000273328.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000273365.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000273366.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000273372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000273375.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Bexarotene |
ENSG00000273375.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Bexarotene |
ENSG00000273381.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Bexarotene |
ENSG00000273396.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000273399.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000273402.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000273402.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000273406.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Bexarotene |
ENSG00000273443.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Bexarotene |
ENSG00000273445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Bexarotene |
ENSG00000273447.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000273454.1 |
Predicted lncRNA |
Sarcoma |
|
| Bexarotene |
ENSG00000273456.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000273456.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000273472.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Bexarotene |
ENSG00000273486.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Bexarotene |
ENSG00000273488.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Bexarotene |
ENSG00000273493.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|